Pharma

Your Article Summary

See Latest Articles

Lumenis Invests in Exclusive, Worldwide License for New Ophthalmic Technology
Corporate News Releases - The Healthcare Sales & Marketing Network, 06/27/06

Lumenis Ltd., a global developer, manufacturer and seller of laser and light-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications, announced that it has received exclusive worldwide licensing rights for SRT(TM), a new laser therapy for selectively treating retinal diseases. These rights include licenses issued to Lumenis by Medizinisches Laserzentrum Lubeck GmbH, Massachusetts General Hospital and Professor Reginald Birngruber

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

Position statement of the Portuguese Society of Nephrology on the clinical use of biotechnological drugs in renal patients
Portuguese Journal of Nephrology and Hypertension, 10/12/09

Orally Disintegrating Tablets: The Effect of Recent FDA Guidance on ODT Technologies and Applications
Pharmaceutical Technology, 10/14/09

Cardiac Cell Repair Therapy: A Clinical Perspective
Mayo Clinic Proceedings, 10/12/09

See All of Biotechnology

Today in Marketing/Media/ROI...keeping you current

Receive free subspecialty "5-minute updates" via email

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

EMEA recommends authorization of swine flu vaccines
Pharmaceutical Technology, 10/14/09

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

See All of Marketing/Media/ROI